Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease tuberous sclerosis
Symptom C0206731|angiofibromas
Sentences 12
PubMedID- 20403796 Cryosurgery: an easy and cheap therapy for facial angiofibromas in tuberous sclerosis.
PubMedID- 22934754 The application of low-dose topical rapamycin (0.003–0.015%) to the face can safely decrease the appearance of facial angiofibromas in patients with tuberous sclerosis complex.
PubMedID- 21861956 Topical rapamycin solution to treat multiple facial angiofibromas in a patient with tuberous sclerosis.
PubMedID- 25336102 Laser treatment of angiofibromas in tuberous sclerosis.
PubMedID- 22552000 Giant angiofibromas in tuberous sclerosis complex: a possible role for localized lymphedema in their pathogenesis.
PubMedID- 24890518 Treatment of nodular facial angiofibromas in tuberous sclerosis, using ultrapulse carbon dioxide laser.
PubMedID- 20698845 Transforming growth factor-beta enhances matrix metalloproteinase-2 expression and activity through akt in fibroblasts derived from angiofibromas in patients with tuberous sclerosis complex.
PubMedID- 22943457 Interestingly, facial angiofibromas associated with tuberous sclerosis also have significantly improved with sirolimus therapy in a case report.
PubMedID- 21410374 Facial angiofibromas associated with tuberous sclerosis.
PubMedID- 24401865 Treatment of angiofibromas in tuberous sclerosis complex: the effect of topical rapamycin and concomitant laser therapy.
PubMedID- 21931059 Dramatic improvement of facial angiofibromas in tuberous sclerosis with topical rapamycin: optimizing a treatment protocol.
PubMedID- 23909960 Vehicle for facial angiofibromas in patients with tuberous sclerosis complex.

Page: 1